HomeAI · summaries
Storia in 3 fonti
Samsung Biologics rights offering highlights future growth, but stock price drops - The Korea Times
Samsung Biologics will issue new shares worth 3 trillion won ($2.17 billion) to finance its planned acquisition of a Swiss-headquartered contract d...
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
Samsung Biologics Announces KRW 3 Trillion Rights Offering to Fund Its Next-Phase Expansion
Samsung Biologics Announces KRW 3 Trillion Rights Offering to Fund Its Next-Phase Expansion
- ·
koreatimes.co.kr
Samsung Biologics to raise $2.17 bil. via rights offering - The Korea Times
Samsung Biologics announced Friday it would raise 3 trillion won ($2.17 billion) through a rights offering as part of efforts to fund investments i...
